Abstract
Biotechnology Law ReportVol. 39, No. 3 As presented by Chris HolmanEagle Pharm., Inc. v. Azar United States Court of Appeals of the District of Columbia, 2020 952 F.3d 323Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN**Published Online:3 Jun 2020https://doi.org/10.1089/blr.2020.29178.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 39Issue 3Jun 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Eagle Pharm., Inc. v. Azar United States Court of Appeals of the District of Columbia, 2020 952 F.3d 323.Biotechnology Law Report.Jun 2020.218-236.http://doi.org/10.1089/blr.2020.29178.cmhPublished in Volume: 39 Issue 3: June 3, 2020PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
